Cargando…

Transcriptome Profile Analysis of Triple-Negative Breast Cancer Cells in Response to a Novel Cytostatic Tetrahydroisoquinoline Compared to Paclitaxel

The absence of chemotherapeutic target hormone receptors in breast cancer is descriptive of the commonly known triple-negative breast cancer (TNBC) subtype. TNBC remains one of the most aggressive invasive breast cancers, with the highest mortality rates in African American women. Therefore, new dru...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gangapuram, Madhavi, Mazzio, Elizabeth A., Redda, Kinfe K., Soliman, Karam F. A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8306781/ https://www.ncbi.nlm.nih.gov/pubmed/34299315 http://dx.doi.org/10.3390/ijms22147694

Ejemplares similares

Synthesis and Biological Evaluations of Ring Substituted Tetrahydroisoquinolines (THIQs) as Anti-Breast Cancer Agents
por: Eyunni, Suresh VK, et al.
Publicado: (2017)

Triple Isozyme Lactic Acid Dehydrogenase Inhibition in Fully Viable MDA-MB-231 Cells Induces Cytostatic Effects That Are Not Reversed by Exogenous Lactic Acid
por: Mazzio, Elizabeth, et al.
Publicado: (2021)

Effect of apigenin on whole transcriptome profile of TNFα-activated MDA-MB-468 triple negative breast cancer cells
por: Bauer, David, et al.
Publicado: (2020)

Thymoquinone Inhibition of Chemokines in TNF-α-Induced Inflammatory and Metastatic Effects in Triple-Negative Breast Cancer Cells
por: Adinew, Getinet M., et al.
Publicado: (2023)

Design, Synthesis and Evaluation of Novel N-Substituted-[Benzoylamino]-5-Ethyl-1,2,3,6-Tetrahydropyridines as Potential Anti-Cancer Agents
por: Henderson, Elizabeth D, et al.
Publicado: (2019)

The Antiproliferative Effects of Flavonoid MAO Inhibitors on Prostate Cancer Cells
por: Zarmouh, Najla O., et al.
Publicado: (2020)

Therapeutic Potential of Thymoquinone in Triple-Negative Breast Cancer Prevention and Progression through the Modulation of the Tumor Microenvironment
por: Adinew, Getinet M., et al.
Publicado: (2021)

The Biochemical and Cellular Basis for Nutraceutical Strategies to Attenuate Neurodegeneration in Parkinson’s Disease
por: Mazzio, Elizabeth A., et al.
Publicado: (2011)

Apigenin inhibits TNFα/IL-1α-induced CCL2 release through IKBK-epsilon signaling in MDA-MB-231 human breast cancer cells
por: Bauer, David, et al.
Publicado: (2017)

Plants against cancer: the immune-boosting herbal microbiome: not of the plant, but in the plant. Basic concepts, introduction, and future resource for vaccine adjuvant discovery
por: Mazzio, Elizabeth, et al.
Publicado: (2023)

Doxorubicin-polyglycerol-nanodiamond conjugate is a cytostatic agent that evades chemoresistance and reverses cancer-induced immunosuppression in triple-negative breast cancer
por: Yuan, Shen-Jun, et al.
Publicado: (2019)

Neurotoxic Effects of Tetrahydroisoquinolines and Underlying Mechanisms
por: Surh, Young-Joon, et al.
Publicado: (2010)

Cocaine potentiates an inflammatory response in C6 astroglia-like cells
por: Agharahimi, Maryam, et al.
Publicado: (2021)

The Prognostic and Therapeutic Implications of the Chemoresistance Gene BIRC5 in Triple-Negative Breast Cancer
por: Adinew, Getinet M., et al.
Publicado: (2022)

Cellular uptake mechanism and comparative evaluation of antineoplastic effects of paclitaxel–cholesterol lipid emulsion on triple-negative and non-triple-negative breast cancer cell lines
por: Ye, Jun, et al.
Publicado: (2016)

Morphine counteracts the effects of paclitaxel in triple-negative breast cancer cells
por: Sezer, Gülay, et al.
Publicado: (2022)

A Novel Paclitaxel Derivative for Triple-Negative Breast Cancer Chemotherapy
por: Liu, Yuetong, et al.
Publicado: (2023)

Rosmarinic acid-induced apoptosis and cell cycle arrest in triple-negative breast cancer cells
por: Messeha, Samia S., et al.
Publicado: (2020)

The Anticancer Effects of Flavonoids through miRNAs Modulations in Triple-Negative Breast Cancer
por: Adinew, Getinet M., et al.
Publicado: (2021)

Steroidomimetic Tetrahydroisoquinolines for the Design of New Microtubule Disruptors
por: Leese, Mathew P., et al.
Publicado: (2011)

The Discovery of Imine Reductases and their Utilisation for the Synthesis of Tetrahydroisoquinolines
por: Cárdenas‐Fernández, Max, et al.
Publicado: (2023)

Methylseleninic Acid Enhances Paclitaxel Efficacy for the Treatment of Triple-Negative Breast Cancer
por: Qi, Yanfeng, et al.
Publicado: (2012)

Weekly Paclitaxel given concurrently with Durvalumab has a favorable safety profile in triple-negative metastatic breast cancer
por: Ghebeh, Hazem, et al.
Publicado: (2021)

1,2,3,4,6-Penta-O-galloylglucose within Galla Chinensis Inhibits Human LDH-A and Attenuates Cell Proliferation in MDA-MB-231 Breast Cancer Cells
por: Deiab, Shihab, et al.
Publicado: (2015)

Anticancer Effects of Fucoxanthin through Cell Cycle Arrest, Apoptosis Induction, and Angiogenesis Inhibition in Triple-Negative Breast Cancer Cells
por: Ahmed, Shade’ A., et al.
Publicado: (2023)

Cytostatics in Indoor Environment: An Update of Analytical Methods
por: Portilha-Cunha, M. Francisca, et al.
Publicado: (2021)

Intrathecal Chemotherapy: Selection of Cytostatic Agents
por: Hayakawa, T., et al.
Publicado: (1970)

The cytostatic activity of cultured Kupffer cells.
por: Pulford, K., et al.
Publicado: (1985)

Molecular mechanism of gossypol mediating CCL2 and IL-8 attenuation in triple-negative breast cancer cells
por: Messeha, Samia S., et al.
Publicado: (2020)

Tetrahydroisoquinolines as novel histone deacetylase inhibitors for treatment of cancer
por: Chen, Danqi, et al.
Publicado: (2016)

Improved simplicity and practicability in copper-catalyzed alkynylation of tetrahydroisoquinoline
por: Gröll, Birgit, et al.
Publicado: (2016)

One-pot chemoenzymatic synthesis of trolline and tetrahydroisoquinoline analogues
por: Zhao, Jianxiong, et al.
Publicado: (2018)

Synthesis of C3/C1-Substituted Tetrahydroisoquinolines
por: Mihoubi, Mohamed, et al.
Publicado: (2015)

BRCA1-IRIS inactivation overcomes paclitaxel resistance in triple negative breast cancers
por: Blanchard, Zannel, et al.
Publicado: (2015)

Nab-paclitaxel for the management of triple-negative metastatic breast cancer: a case study
por: Arpino, Grazia, et al.
Publicado: (2015)

Cisplatin versus carboplatin in combination with paclitaxel as neoadjuvant regimen for triple negative breast cancer
por: Huang, Liang, et al.
Publicado: (2017)

Transcytosable Peptide-Paclitaxel Prodrug Nanoparticle for Targeted Treatment of Triple-Negative Breast Cancer
por: Wang, Longkun, et al.
Publicado: (2023)

Effects of gossypol on apoptosis-related gene expression in racially distinct triple-negative breast cancer cells
por: Messeha, Samia S., et al.
Publicado: (2019)

Evaluation of the Inhibitory Effects of Bavachinin and Bavachin on Human Monoamine Oxidases A and B
por: Zarmouh, Najla O., et al.
Publicado: (2015)

Gene Expression Alterations Associated with Oleuropein-Induced Antiproliferative Effects and S-Phase Cell Cycle Arrest in Triple-Negative Breast Cancer Cells
por: Messeha, Samia S., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_s1h2vum90jld6hllcrqocbkk3d